Clene (NASDAQ: CLNN) director awarded 4,361 stock options at $6.81 strike

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Clene Inc. director Alison Mosca reported receiving two grants of stock options as part of her compensation. One grant covers 2,861 options for common stock at an exercise price of $6.81 per share and vests immediately. A second grant covers 1,500 options at the same $6.81 exercise price and vests in 12 equal monthly installments on the 21st of each month beginning June 21, 2026. Both option awards expire on May 20, 2036, and represent equity-based awards rather than open-market share purchases or sales.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Mosca Alison

Role null

Type	Security	Shares	Price	Value
Grant/Award	stock option	1,500	$0.00	--
Grant/Award	stock option	2,861	$0.00	--

Holdings After Transaction: stock option — 1,500 shares (Direct, null)

Footnotes (1)

This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested. This option was granted on May 21, 2026 as an option for 2,861 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

Key Figures

Option grant size: 2,861 options Second option grant size: 1,500 options Exercise price: $6.81 per share +3 more

6 metrics

Option grant size 2,861 options Immediate-vesting stock option grant to director Alison Mosca

Second option grant size 1,500 options Stock option grant vesting in 12 monthly installments

Exercise price $6.81 per share Exercise price for both option grants under Amended 2020 Stock Plan

Total options granted 4,361 options Combined size of the two option awards reported

Vesting start date June 21, 2026 Start of 12 monthly vesting installments for 1,500-option grant

Option expiration May 20, 2036 Expiration date for both stock option grants

Key Terms

stock option, exercise price, vests immediately upon grant, Amended 2020 Stock Plan, +1 more

5 terms

stock option financial

"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"at an exercise price of $6.81 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests immediately upon grant financial

"The options vest immediately upon grant."

Amended 2020 Stock Plan financial

"under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81"

equal monthly installments financial

"The options vest in 12 equal monthly installments on the 21st day"

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 02:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mosca Alison

(Last)

(First)

(Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY

UTAH

84121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
stock option	$6.81	05/21/2026		A		1,500		⁽¹⁾	05/20/2036	common stock	1,500	$0	1,500	D
stock option	$6.81	05/21/2026		A		2,861		⁽²⁾	05/20/2036	common stock	2,861	$0	2,861	D

Explanation of Responses:

1. This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

2. This option was granted on May 21, 2026 as an option for 2,861 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Clene (CLNN) director Alison Mosca report in this Form 4 filing?

Alison Mosca reported receiving two stock option grants from Clene Inc. The awards cover 2,861 and 1,500 options for common stock at a $6.81 exercise price, reflecting equity compensation rather than open-market trading activity.

How many Clene (CLNN) stock options were granted to Alison Mosca and at what price?

Mosca was granted 2,861 stock options and a separate 1,500-option award. Both grants relate to Clene common stock with an exercise price of $6.81 per share under the company’s Amended 2020 Stock Plan.

What are the vesting terms of Alison Mosca’s new Clene (CLNN) stock options?

One option grant for 2,861 shares vests immediately upon grant. The second grant for 1,500 shares vests in 12 equal monthly installments on the 21st day of each month, starting June 21, 2026, until fully vested.

When do the newly granted Clene (CLNN) stock options to Alison Mosca expire?

Both stock option grants to Alison Mosca expire on May 20, 2036. After that expiration date, any unexercised options become worthless, so exercises must occur before that date for her to acquire Clene common shares.

Are Alison Mosca’s Clene (CLNN) Form 4 transactions open-market buys or sales?

The reported transactions are stock option awards classified as grants or other acquisitions. They are not open-market purchases or sales; instead, they represent equity compensation awarded under Clene’s Amended 2020 Stock Plan.